Glenmark Pharmaceuticals
Glenmark Pharmaceuticals is a leading global pharmaceutical and biopharmaceutical company that researches, develops, manufactures and markets a broad range of branded and generic formulations, biologics, and active pharmaceutical ingredients. Established in 1977, the company boasts of a presence across the world in more than 70 countries. It has multiple R&D centers across India, the USA, Switzerland, and Brazil. Strongly committed to social responsibility, the company has its own charitable initiative, ‘Gharelu Uphaar'. There product portfolio covers a wide range of therapeutic areas including dermatology, respiratory, diabetes, oncology, and critical care. Targeting doctors, pharmacists, and patients, Glenmark strives to provide innovative and quality healthcare solutions. The company is best known for providing go-to market strategy for launches of new products, rapidly changing its production to meet regulatory requirements, and stringent quality control standards.